Capping the worst day on the sports betting calendar

With Major League Baseball resuming regularly scheduled ball games this Friday, the first day following the All-Star Game represents the quietest day on the sports betting calendar.

Even the Tour de France had a bit of an off day. Wednesday in the Tour means it's Stage 17, which represents a timed trial in the celebrated cycling event. In case you missed it, Christopher Froome won the stage to extend his overall lead and is now -2,000 (Bet365) to win outight.

Here is a look at the other events on Wednesday's schedule.

WNBA

Tulsa Shock vs. Seattle Storm (-6, 144)

* Tulsa: 3-13 SU, 8-8 ATS, 9-6-1 O/U
* Seattle: 6-8 SU, 7-7 ATS, 4-10 O/U
* Tulsa has defeated Seattle in both matchups this season. They are 2-0 ATS in those games.
* The over is 4-1 in the last five meetings.

Atlanta Dream vs Los Angeles Sparks (-10.5, 160.5)

* Atlanta: 10-3 SU, 9-4 ATS, 7-6 O/U
* Los Angeles: 10-4 SU, 7-7 ATS, 5-9 O/U
* Atlanta is 0-4 ATS in its last four road games.
* Los Angeles is 13-6-2 ATS in its last 21 games following an ATS win.

MLS

Colorado vs. New England (-118, +230, +350)


* Colorado is the only MLS side with no players called up to their respective national teams for the Gold Cup.
* There has been under 2.5 goals in nine of New England's last 11 away matches.
* Colorado are unbeaten in their last 10 home games against New England.

Chivas USA vs. Toronto FC (+130, +230, +210)


* Toronto striker Danny Koevermans will be out four weeks due to injury.
* Chivas is 5-0 in its last five home matches against Toronto.
* Chivas has not won in its last 14 MLS matches.

*** MLS odds courtesy of Bet365.

If you have any feedback or suggestions for our Editorial Team, please contact us at Editorial

            share   SHARE   rss   RSS FEED   email   EMAIL   print   PRINT

There haven't been any comments posted on this article. Be the first to respond!

You are currently not logged in.
Login | Signup | Help
You must be logged in to post a comment.

Top Response

There have been no comments on this article. Be the first to respond!